La dysbiose intestinale dans les maladies inflammatoires chroniques de l’intestin

Huang, 2017, Fine-mapping inflammatory bowel disease loci to single-variant resolution, Nature, 547, 173, 10.1038/nature22969 Birrenbach, 2004, Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications, Inflamm Bowel Dis, 10, 848, 10.1097/00054725-200411000-00019 Maslowski, 2009, Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43, Nature, 461, 1282, 10.1038/nature08530 Marteau P, Doré J, Seksik P. Microbiote et Mici. POST’U. FMC-HGE. Hugot, 2001, Association of NOD2 leu-cine-rich repeat variants with susceptibility to Crohn’s disease, Nature, 411, 599, 10.1038/35079107 Jostins, 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 Umicevic Mirkov, 2017, Genetics of inflammatory bowel disease: beyond NOD2, Lancet Gastroenterol Hepatol, 2, 224, 10.1016/S2468-1253(16)30111-X Elson, 1995, Experimental models of inflammatory bowel disease Gastroenterology, 109, 1344 Robert, 1977, Resistance of germfree rats to indomethacin-in-duced intestinal lesions, Prostaglandins, 14, 333, 10.1016/0090-6980(77)90178-2 Kim, 2005, Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria, Gastroenterology, 128, 891, 10.1053/j.gastro.2005.02.009 Winslet, 1994, Faecal diversion for Crohn’s colitis: a model to study the role of the faecal stream in the inflammatory process, Gut, 35, 236, 10.1136/gut.35.2.236 Harper, 1983, Split ileostomy and ileoco-lostomy for Crohn’s disease of the colon and ulcerative colitis: a 20 year survey, Gut, 24, 106, 10.1136/gut.24.2.106 Burman, 1971, The effects of diversion of intestinal contents on the progress of Crohn’s disease of the large bowel, Gut, 12, 11, 10.1136/gut.12.1.11 Rutgeerts, 1991, Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum, Lancet, 338, 771, 10.1016/0140-6736(91)90663-A Lepage, 2013, A metagenomic insight into our gut’s microbiome, Gut, 62, 146, 10.1136/gutjnl-2011-301805 Lagier, 2015, The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota, Clin Microbiol Rev, 28, 237, 10.1128/CMR.00014-14 Weissenbach, 2016, Microbiotes and metagenomics, Med Sci, 32, 937 Sokol, 2008, Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proc Natl Acad Sci U S A, 105, 16731, 10.1073/pnas.0804812105 Quévrain, 2016, Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease, Gut, 65, 415, 10.1136/gutjnl-2014-307649 Sokol, 2010, The intestinal microbiota in inflammatory bowel diseases: time to connect with the host, Curr Opin Gastroenterol, 26, 327, 10.1097/MOG.0b013e328339536b Chiodini, 2015, Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn’s Disease of the Ileum, PLoS One, 10, e0134382, 10.1371/journal.pone.0134382 Wright, 2015, Recent advances in characterizing the gastrointestinal microbiome in Crohn’s disease: a systematic review, Inflamm Bowel Dis, 21, 1219 Darfeuille-Michaud, 1998, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease, Gastroenterology, 115, 1405, 10.1016/S0016-5085(98)70019-8 Sokol, 2017, Fungal microbiota dysbiosis in IBD, Gut, 66, 1039, 10.1136/gutjnl-2015-310746 Norman, 2015, Disease-specific alterations in the enteric virome in inflammatory bowel disease, Cell, 160, 447, 10.1016/j.cell.2015.01.002 Busquets, 2015, Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s Disease, J Crohns Colitis, 9, 899, 10.1093/ecco-jcc/jjv119 Kolho, 2015, Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation, Am J Gastroenterol, 110, 921, 10.1038/ajg.2015.149 Rajca, 2014, Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease, Inflamm Bowel Dis, 20, 978 Magro, 2017, Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis, Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis, 11, 649 Gionchetti, 2017, 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations, J Crohns Colitis, 11, 135, 10.1093/ecco-jcc/jjw169 Gionchetti, 2003, Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial, Gastroenterology, 124, 1202, 10.1016/S0016-5085(03)00171-9 Gionchetti, 2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a doubleblind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370 Mimura, 2004, Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, 53, 108, 10.1136/gut.53.1.108 Moayyedi, 2015, Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial, Gastroenterology, 149, 102, 10.1053/j.gastro.2015.04.001 Paramsothy, 2019, Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis, Gastroenterology, 156, 1440, 10.1053/j.gastro.2018.12.001 Costello, 2019, Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial, JAMA, 321, 156, 10.1001/jama.2018.20046 Sokol, 2020, Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study, Microbiome, 8, 12, 10.1186/s40168-020-0792-5 Rossen, 2015, Findings from a randomized controlled trial of fecal transplantation for patients with ulce-rative colitis, Gastroenterology, 149, 110, 10.1053/j.gastro.2015.03.045